Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insight Molecular Diagnostics (IMDX) Change in Account Payables (2020)

Historic Change in Account Payables for Insight Molecular Diagnostics (IMDX) over the last 1 years, with Q1 2020 value amounting to -$6000.0.

  • Insight Molecular Diagnostics' Change in Account Payables changed N/A to -$6000.0 in Q1 2020 from the same period last year, while for Dec 2020 it was -$6000.0, marking a year-over-year change of. This contributed to the annual value of -$6000.0 for FY2020, which is 9971.35% up from last year.
  • As of Q1 2020, Insight Molecular Diagnostics' Change in Account Payables stood at -$6000.0.
  • In the past 5 years, Insight Molecular Diagnostics' Change in Account Payables registered a high of -$6000.0 during Q1 2020, and its lowest value of -$6000.0 during Q1 2020.